图表内容
图表28:GEN1046临床I/IIa期试验治疗有效性
■Colorectal cancer■NSCLC■Ovarian cancer■Pancreatic cancer■Other cancer◇Prior anti--PD-i/PDL1 treatment△Ongoing treatment
PDPD
PD
PDPD
PD
PD
PDPDSDSDSD
SDSD
SD
UPR
-80
-100
Dose
CPS
7012310.5001010NE0°450NE2580NENE10250NE0.5305000NE731NE5001515130NE0035025125005
TPS
%
0.50002000001NE0350NE0.5050NENE00050NE010000NE0510.5NE00008000NE0000010.530
Bc时t response
NA
PD
PD
PRSD SD PDPD
SD SD SD NANA
NA CRPR
PD PR
PR PD
资科来源:NCBI
东方财富证券研究所